Polhemus, Mark E <br/><br/>
Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Apr 2008 
 - 1493-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.01367-07  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Animals<br/>Antimalarials--therapeutic use<br/>Atovaquone--therapeutic use<br/>Chemoprevention<br/>Humans<br/>Kaplan-Meier Estimate<br/>Kenya<br/>Malaria Vaccines--administration & dosage<br/>Malaria, Falciparum--drug therapy<br/>Parasitemia--drug therapy<br/>Plasmodium falciparum--drug effects<br/>Proguanil--therapeutic use<br/>Time Factors